In recent years, Apos have been found to be strongly associated with the risk of STEMI, and Apo B/A1 ratio is a better risk biomarker of acute myocardial infarction than LDL-C or TC/HDL-C ratio [8, 9]. The gene discussed is APOB; the disease is myocardial infarction.